gt-faq: how is gene expression evaluated in gene therapy clinical trials?
Published 3 years ago • 224 plays • Length 2:34Download video MP4
Download video MP3
Similar videos
-
2:31
gt-faq: how is a treatment’s impact on a disease evaluated in a gene therapy clinical trial?
-
2:45
gt-faq: how is safety measured in a gene therapy clinical trial?
-
2:50
gt-faq: how long is gene therapy expected to last?
-
2:31
gt-faq: what are eligibility criteria for gene therapy clinical trials?
-
2:41
gt-faq: is gene therapy specific to a mutation?
-
2:18
gene therapy assessments in clinical trials
-
2:41
gt-faq: why are steroids used in gene transfer therapy clinical trials?
-
2:22
gt-faq: what is the goal of gene transfer therapy?
-
2:16
gt faq: is genetic testing required to receive gene therapy?
-
3:26
gt-faq: what is the difference between gene editing and gene therapy?
-
2:25
gt-faq: is genetic testing required to receive gene therapy? (spanish subtitles)
-
2:11
gt-faq: does gene transfer therapy change a person’s genes?
-
1:55
gt-faq: how are gene transfer therapies made?
-
2:42
gt-faq: what are pre-existing antibodies and why do they matter to gene therapy? (spanish subtitles)
-
18:41
in the pipeline: gene therapy - sarepta therapeutics
-
4:13
what are the essential components of gene therapy?
-
3:26
gt-faq: what is the difference between gene editing and gene therapy? (spanish subtitles)
-
2:33
gt-faq: is there a universal test that screens for antibodies to gene transfer therapy?